Clinical Infectious Diseases · 2000 · 137 citations · 15 references
MedicineInfectious DiseasesPediatricsMolecular VirologyPediatric Infectious DiseasesVirologyAntiviral TherapyEncephalitisViral DiagnosticsViral InfectionsAcyclovir TherapyCerebrospinal Fluid SystemCoxsackievirus InfectionsHerpes Simplex Virus EncephalitisHerpes Simplex Virus TestingRelapse IncidenceTotal Dose
Herpes simplex encephalitis (HSE) in children sometimes exacerbates after successful treatment; yet the frequency, etiology, and clinical features of exacerbation remain unclear. We report data for 27 children with HSE confirmed by polymerase chain reaction (PCR) analysis; all were successfully treated with acyclovir, but 7 (26%) had a relapse of encephalitic illness. In 2 of those 7, serial examination with a PCR assay showed that herpes simplex virus (HSV) DNA reappeared temporarily in the cerebrospinal fluid (CSF). For 5 of the 7 patients, a second course of acyclovir therapy was effective. Coxsackievirus A9 was isolated from CSF of 1 case patient during subsequent exacerbation. The total dose during initial acyclovir therapy was significantly lower in the relapse group than in the control group (P=.027). In conclusion, exacerbation of HSE in children may be more common than previously recognized. It is suggested that the replication of HSV or another viral pathogen caused a second encephalitic illness (HSE) in some cases.
15
ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS
Birgit Sköldenberg, Kjell Alestig, Lars Burman et al. · The Lancet · 1984 · 610 citations
C R Kjeldsberg, E. H. Macintyre, A. E. Vatter et al. · The Lancet · 1986 · 465 citations
Richard J. Whitley, Martin Hirsch, Adolf W. Karchmer et al. · New England Journal of Medicine · 1981 · 304 citations